AstraZeneca Launches Direct-To-Consumer Platform to Expand Access to Medications for US Patients, Including Those Living With Chronic Conditions
September 27, 2025
	September 27, 2025
WILMINGTON, Delaware, Sept. 27 -- AstraZeneca, a biopharmaceutical company, issued the following news release on Sept. 26, 2025:
* * *
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
AstraZeneca Direct is designed to offer greater convenience
*
AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to . . .
* * *
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
AstraZeneca Direct is designed to offer greater convenience
*
AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to . . .
